Roche’s Columvi improves survival in large B-cell lymphoma
Approximately 160,000 people are diagnosed with this aggressive form of cancer each year
Read More
Section: Research
Novo Nordisk presents new findings on semaglutide in Alzheimer’s disease
While the trials did not meet their primary endpoints, they highlighted important biomarker findings
Read More
Pfizer’s Hympavzi significantly reduces bleeds in haemophilia patients
Over 800,000 people worldwide live with haemophilia
Read More
Gilead’s Yescarta shows benefits for patients with large B-cell lymphoma
This is the most common type of non-Hodgkin lymphoma worldwide
Read More
Vandria announces positive phase 1 data for Alzheimer’s treatment
Trial data showed that VNA-318 has the ability to penetrate the brain
Read More